Bid Publish Date
06-Jun-2025, 2:21 pm
Bid End Date
27-Jun-2025, 3:00 pm
Location
Progress
Quantity
21400
The issuing authority invites bids for ISONIAZID 300MG TAB, LENALIDOMIDE 5 MG CAP, LETROZOLE 2. 5MG TAB, LEVODOPA 100MG plus CARBIDOPA 10MGTAB in CENTRAL DELHI, DELHI. Quantity: 21400. Submission Deadline: 27-06-2025 15: 00: 00. Submit your proposal before the deadline.
Tender Category
Goods
Bid To RA
No
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
ISONIAZID 300MG TAB
ISONIAZID 300MG TAB
LENALIDOMIDE 5 MG CAP
LENALIDOMIDE 5 MG CAP
LETROZOLE 2.5MG TAB
LETROZOLE 2.5MG TAB
LEVODOPA 100MG plus CARBIDOPA 10MGTAB
LEVODOPA (100MG) + CARBIDOPA (10MG) TAB
LEVODOPA 200 MG plus CARBIDOPA 50 MG CR TAB
LEVODOPA 200 MG + CARBIDOPA 50 MG CR TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | ISONIAZID 300MG TAB | ISONIAZID 300MG TAB | 800 | no | [email protected] | 15 | |
| 2 | LENALIDOMIDE 5 MG CAP | LENALIDOMIDE 5 MG CAP | 900 | no | [email protected] | 15 | |
| 3 | LETROZOLE 2.5MG TAB | LETROZOLE 2.5MG TAB | 10,700 | no | [email protected] | 15 | |
| 4 | LEVODOPA 100MG plus CARBIDOPA 10MGTAB | LEVODOPA (100MG) + CARBIDOPA (10MG) TAB | 3,000 | no | [email protected] | 15 | |
| 5 | LEVODOPA 200 MG plus CARBIDOPA 50 MG CR TAB | LEVODOPA 200 MG + CARBIDOPA 50 MG CR TAB | 6,000 | no | [email protected] | 15 |
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | chemo biological Under PMA | - | 19-06-2025 13:59:08 | |
| 2 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITED Under PMA | - | 27-06-2025 14:28:07 | |
| 3 | FAIRDEAL HEALTH CARE PRIVATE LIMITED Under PMA | - | 27-06-2025 11:31:14 | |
| 4 | GOYAL MEDICAL & GENERAL AGENCY Under PMA | - | 24-06-2025 15:34:44 | |
| 5 | GOYAL PHARMACEUTICALS Under PMA | - | 27-06-2025 11:10:01 | |
| 6 | JAI GANESH PHARMACEUTICALS Under PMA | - | 27-06-2025 14:14:57 | |
| 7 | MAHAVIR PHARMACEUTICALS Under PMA | - | 27-06-2025 13:44:09 | |
| 8 | MAMMOTH LIFESCIENCES LLP Under PMA | - | 26-06-2025 18:58:05 | |
| 9 | PRAKASH MEDICOS Under PMA | - | 27-06-2025 10:49:51 | |
| 10 | PUSHYA MEDISURG Under PMA | - | 26-06-2025 15:26:02 | |
| 11 | SARV REMEDI HEALTHCARE Under PMA | - | 27-06-2025 14:50:07 | |
| 12 | SB LIFESCIENCES PRIVATE LIMITED Under PMA | - | 14-06-2025 14:24:53 | |
| 13 | SMPL LIFE SCIENCES PRIVATE LIMITED Under PMA | - | 27-06-2025 13:43:16 | |
| 14 | SRI G PHARMACEUTICALS Under PMA | - | 07-06-2025 16:35:37 | |
| 15 | SUKUN PHARMA Under PMA | - | 17-06-2025 18:20:03 |
Key insights about DELHI tender market
The eligibility requirements include being a registered entity in the pharmaceutical sector with valid licenses, having experience in supplying similar pharmaceutical goods, and meeting all regulatory demands established by health authorities.
The submission must include proof of eligibility, technical compliance certificates, financial documents displaying pricing structure, and additional documentation indicating adherence to quality standards and requirements as mandated within the tender scope.
Interested bidders should register on the designated platform outlined in the tender notice. Post-registration, documents should be uploaded through the specified submission portal, ensuring all formats comply with the necessary electronic document submission requirements.
Payment terms typically include conditions concerning advance payments, milestones, and settlements upon successful delivery of goods. Bidders should review the tender document carefully to understand the full financial obligations and conditions prescribed therein.
Yes, there are specific benefits available for MSEs and startups under this tender. These may include relaxed qualification criteria, simplified documentation processes, and incentives to encourage local supplier participation all aimed at promoting national industrial growth under the Make in India initiative.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS